Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Top Three Dividend Stocks On Euronext Paris For July 2024

In This Article:

As of July 2024, the French market, along with other European indices, has shown resilience with the CAC 40 Index experiencing a modest rise. This positive trajectory in Europe comes amidst a broader context of easing inflation pressures in the U.S., which has brought some optimism to global markets. In such an environment, dividend stocks continue to be a focal point for investors seeking stable returns amid fluctuating market conditions.

Top 10 Dividend Stocks In France

Name

Dividend Yield

Dividend Rating

Rubis (ENXTPA:RUI)

7.06%

★★★★★★

CBo Territoria (ENXTPA:CBOT)

6.86%

★★★★★★

Métropole Télévision (ENXTPA:MMT)

9.67%

★★★★★☆

Carrefour (ENXTPA:CA)

6.04%

★★★★★☆

Teleperformance (ENXTPA:TEP)

3.71%

★★★★★☆

Arkema (ENXTPA:AKE)

4.10%

★★★★★☆

Sanofi (ENXTPA:SAN)

4.09%

★★★★★☆

VIEL & Cie société anonyme (ENXTPA:VIL)

4.04%

★★★★★☆

Exacompta Clairefontaine (ENXTPA:ALEXA)

4.35%

★★★★★☆

Piscines Desjoyaux (ENXTPA:ALPDX)

8.81%

★★★★★☆

Click here to see the full list of 38 stocks from our Top Euronext Paris Dividend Stocks screener.

We'll examine a selection from our screener results.

Arkema

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Arkema S.A. is a global manufacturer and seller of specialty chemicals and advanced materials, with a market capitalization of approximately €6.38 billion.

Operations: Arkema S.A.'s primary revenue streams include €3.50 billion from Advanced Materials, €2.70 billion from Adhesive Solutions, €2.36 billion from Coating Solutions, and €737 million from Intermediates.

Dividend Yield: 4.1%

Arkema, trading at €57.1% below its estimated fair value, offers a modest dividend yield of 4.1%. Despite this lower yield relative to the top French dividend payers, both its earnings and cash flows substantiate its dividends with payout ratios of 74.9% and 45.9%, respectively. Arkema's dividends have shown stability and reliability over the past decade, with consistent growth in payments despite recent profit margins dropping to 3.7% from last year's 6.7%. Recent collaborations, such as with ProLogium for battery development, highlight its strategic moves in innovative sectors.

ENXTPA:AKE Dividend History as at Jul 2024
ENXTPA:AKE Dividend History as at Jul 2024

Boiron

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Boiron SA is a company that manufactures and distributes homeopathic medicines across France, other parts of Europe, North America, and internationally, with a market capitalization of approximately €557.33 million.

Operations: Boiron SA generates €493.25 million primarily through the manufacture and marketing of homeopathic medicines and other healthcare solutions.